McCarthy, Caroline, Sacco, Joseph, Fedele, Stefano, Ho, Michael, Porter, Stephen, Liloglou, Triantafillos ORCID: 0000-0003-0460-1404, Greenhalf, Bill, Robinson, Max, Young, Bridget
ORCID: 0000-0001-6041-9901, Cicconi, Silvia et al (show 5 more authors)
(2021)
SAVER: sodium valproate for the epigenetic reprogramming of high-risk oral epithelial dysplasia-a phase II randomised control trial study protocol.
TRIALS, 22 (1).
This is the latest version of this item.
Text
SAVER trial protocol paper.pdf - OA Published Version Download (1MB) | Preview |
Item Type: | Article |
---|---|
Uncontrolled Keywords: | Oral epithelial dysplasia, Sodium valproate, Epigenetic reprogramming, Drug repurposing, Randomised controlled trial, Chemoprevention |
Divisions: | Faculty of Health and Life Sciences Faculty of Health and Life Sciences > Institute of Population Health Faculty of Health and Life Sciences > Institute of Systems, Molecular and Integrative Biology |
Depositing User: | Symplectic Admin |
Date Deposited: | 15 Jul 2021 09:10 |
Last Modified: | 25 May 2022 07:11 |
DOI: | 10.1186/s13063-021-05373-8 |
Open Access URL: | https://trialsjournal.biomedcentral.com/articles/1... |
Related URLs: | |
URI: | https://livrepository.liverpool.ac.uk/id/eprint/3130119 |
Available Versions of this Item
-
SAVER: sodium valproate for the epigenetic reprogramming of high-risk oral epithelial dysplasia-a phase II randomised control trial study protocol. (deposited 08 Jul 2021 10:42)
- SAVER: sodium valproate for the epigenetic reprogramming of high-risk oral epithelial dysplasia-a phase II randomised control trial study protocol. (deposited 15 Jul 2021 09:10) [Currently Displayed]
Dimensions
Altmetric
Share
CORE (COnnecting REpositories)